Amide derivatives bearing a cyclopropylaminoacarbonyl substituent useful as cyto kine inhibitors

Details for Australian Patent Application No. 2004303579 (hide)

Owner AstraZeneca AB

Inventors Cumming, John Graham; Nash, Ian Alun; Brown, Dearg Sutherland

Agent Freehills

Pub. Number AU-B-2004303579

PCT Pub. Number WO2005/061465

Priority 0329572.2 20.12.03 GB

Filing date 15 December 2004

Wipo publication date 7 July 2005

Acceptance publication date 3 April 2008

International Classifications

C07D 213/30 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 277/24 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 285/06 (2006.01) Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

Event Publications

15 June 2006 PCT application entered the National Phase

  PCT publication WO2005/061465 Priority application(s): WO2005/061465

3 April 2008 Application Accepted

  Published as AU-B-2004303579

31 July 2008 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004303582-Use of metal complex compounds as oxidation catalysts

2004303572-Open cell polymer foams having a very small diameter, and the production method thereof